期刊文献+

晚期糖化终产物受体反义RNA腺相关病毒载体的构建及在肾脏系膜细胞中表达 被引量:2

Construction of recombinant RAGE antisense RNA adeno-associated virus vector and its expression in rat mesangial cell
暂未订购
导出
摘要 目的构建晚期糖化终产物受体(RAGE)反义RNA腺相关病毒载体,并在大鼠肾脏系膜细胞中表达。方法构建腺相关病毒介导的RAGE反义RNA载体,3个质粒共转染293细胞,获得病毒原液,感染大鼠肾脏系膜细胞,流式细胞术、RT-PCR、ELISA检测重组病毒感染的细胞RAGE的表达和分泌细胞外基质的情况。结果经酶切鉴定、序列分析显示RAGE基因片段正确完整反向插入pAAV-MCS。利用293细胞包装获得病毒原液的滴度为8.7×107VP/mL。感染重组病毒的细胞与正常细胞比较RAGE表达被抑制(48.2±6.1)%,分泌Ⅳ型胶原(ColⅣ)水平明显下降(P<0.05)。结论成功构建具有抑制功能的RAGE反义RNA腺相关病毒载体,为进一步研究RAGE的作用机制,以及基因治疗RAGE相关疾病提供一个重要工具。 Objective To construct recombinant receptor for advanced giycation endpreduets (RAGE)anfisense RNA adeno-associated virus vector and express the vector in rat mesangial cell. Methods Total RNA was acquired by TRIZOL method and the gene fragment of rat RAGE was amplified by RT-PCR. The target gene was connected to pAAV-MCS vector, and then identified by restriction endonuclease digestion and DNA sequence analysis. Recombinant AAV-RAGE- was derived by co-transfecting DNAs of rAAV-RAGE- , pAAV-RC, and pAAV- helper into AAV-293 cells using liposome methods. The titer of recombinant AAV-RAGE- was calculated by staining the cells expressed the re- port gene LacZ with X-Gal. After transduction of recombinant AAV-RAGE- in rat mesangial cell, flow cytometry (FCM) and RT-PCR were used to determine the expression of RAGE and ELISA was used to examine the levels of fibronectin (FN) and type IV collagen ( Col Ⅳ ) in cell supematant inducedby AGEs. Results The recombinant AAV-RAGE- wasobtainedwiththetiters of 8.7×10^7 viruspartieles/mL. AfterAG- Es induction, the expressions of RAGE was inhibited by (48.2 ± 6.1 ) % and the amount of Col Ⅳ in the medium was lower than that of vector virus transducted coils ( P 〈 0.05). Conlusion The success in constructing recombinant AAV/RAGE- promotes the further research in melecular biology of RAGE and the recombinant AAV/RAGE- can be potentially used in gene therapy for RAGE associated diseases.
出处 《免疫学杂志》 CAS CSCD 北大核心 2007年第2期135-138,143,共5页 Immunological Journal
基金 福建省科技开发计划项目(2003D09) 福建省卫生厅青年科研基金(2004-1-1)资助
关键词 反义RNA 晚期糖化终产物受体 腺相关病毒 Antisense RNA Receptor for advanced glycation endproducts Adeno-associated virus vector
  • 相关文献

参考文献9

  • 1Stern D, Yah SD, Yah SF, et al. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings[J]. Adv Drug Deliv Rev,2002, 54 (12): 1 615- 1 625.
  • 2郭志坚,侯凡凡,张训,刘志强,王力.晚期糖基化终产物通过p38信号通路抑制内皮细胞合成一氧化氮的研究[J].中华医学杂志,2002,82(19):1328-1331. 被引量:20
  • 3Schmidt AM, Yan SD, Yan SF, et al. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses[J]. J Clin Invest, 2001, 108 (7):949 - 955.
  • 4Bierhaus A, Schiekofer S, Schwaninger M, et al.Diabetesassociated sustained activation of the transcription factor nuclear factor-κB[J]. Diabetes, 2001, 50(12): 2 792-2808.
  • 5Takeda R, Suzuki E, Satonaka H, et al. Blockade of endogenous cytokines mitigates neointimal formation in obese Zucker rats [ J ]. Circulation, 2005, 111 ( 11 ) : 1 398 -1406.
  • 6Wang K, Zhou Z, Zhang M, et al. Peroxisome proliferatoractivated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid arteryinjury model[J]. J Pharmacol Exp Ther, 2006, 317 (1):37 - 43.
  • 7Marx N, Walcher D, Ivanova N, et al. Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products[J]. Diabetes, 2004, 53 (10): 2 662-2668.
  • 8Flyvbjerg A, Denner L, Schrijvers BF, et al. Long-term renal effects of a neutralizing RAGE antibody in obese type 2 Diabetic mice[J]. Diabetes, 2004,53(1):166- 172.
  • 9Yah SS, Wu ZY, Zhang liP, et al. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system[J]. Nat Med, 2003, 9(3): 287-293.

二级参考文献22

  • 1Odctti P,Forgarty J,Sell DR,et al. Chromatographic quantitition of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes, 1992,41: s153-159.
  • 2Miyata T,Kurokawa K,van Ypersele de Strihou C. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int,2000,58: 120-125.
  • 3Lyons TJ: Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol, 1993, 71: 26B-31B.
  • 4Josse C,Boelaert JR,Best-Belpomme M,et al. Importance of post-transcriptional regulation of chemokine genes by oxidative stress. Biochem J, 2001,360: 321-333.
  • 5Hou FF,Boyce J,Chertow GM,et al. Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin. J Am Soc Nephrol,1998 , 9: 277-283.
  • 6鄂征. 内皮细胞培养. 见:鄂征主编,组织培养和分子细胞学技术. 北京:北京出版社, 1999.125-126.
  • 7庞战军. Griess 试剂法. 见:庞战军,陈瑗,周玫著,自由基医学研究方法,224-226.
  • 8Bergstrom J. Inflammation, malnutrition, cardiovascular disease and mortality in end-stage renal disease. Pol Arch Med Wewn,2000,104: 641-643.
  • 9Luft FC. Renal disease as a risk factor for cardiovascular disease. Basic Res Cardiol, 2000, 95: I72-I76.
  • 10Hangaishi M,Taguchi J,Miyata T,et al. Increased aggregation of human platelets produced by advanced glycation end products in vitro. Biochem Biophys Res Commun, 1998,248: 285-292.

共引文献19

同被引文献15

  • 1张丽娟,田野苹,沈娟,闵彦,应楹.α-黑素细胞刺激素处理的树突状细胞对小鼠心脏移植物存活时间的影响[J].第二军医大学学报,2005,26(2):143-146. 被引量:2
  • 2沈娟,田野苹,张丽娟,闵彦,武向峰.α-黑素细胞刺激素对同种异体小鼠异位心脏移植排斥反应的抑制作用[J].解放军药学学报,2006,22(1):8-11. 被引量:1
  • 3Wood K J, Prior TG. Gene therapy in transplantation [ J ]. Curr Opin Mol Ther, 2001, 3(4) : 390- 398.
  • 4Chen CH, Kuo LM, Chang Y, et al. In vivo immune modulatory activity of hepatic stellate cells in mice [ J ]. Hepatology, 2006, 44(5): 1 171- 1 181.
  • 5Streck C J, Zhou J, Ng CY, et al. Long term recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in nfice with disseminated neuroblastoma[J].Am Coll Surg, 2004, 199(1): 78-86.
  • 6Tenenbaum L, Lehtonen E, Monahan PE. Evaluation of risks related to the use of adeno-associated virus-based vectors [J]. Curr Gene Ther, 2003, 3(6) : 545 - 565.
  • 7Yang ZF, Wu XB, Tsui TY, et ol. Recombination adenoassociated virus vector: is ideal for gene delivery in liver transplantation[J]. Liver Transpl, 2003, 9(4): 411- 420.
  • 8Lalani AS, Chang B, Lin J, et al. Anti tmnor efficiency of human angiostatin using liver-mediated adeno-associated virus gene therapy [J].Mol Ther, 2004, 9(1) : 56- 66.
  • 9Raper SE, Wilson JM. Cell transplantation in liver directed gene therapy [J]. Cell Transplant, 1993, 2(5) : 381 - 400.
  • 10Miao CH, Nakai H, Thompson AR, et al. Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction [J]. Virol, 2000, 74(8) : 3 793 - 3 833.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部